This announcement is a separate document:
荣昌生物关于调整公司2024年度向特定对象发行A股股票方案的公告
Remegen announces the adjustment of its 2024 A-share stock issuance plan for specific targets.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.